Paper · 925886
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 27
Download this page as JSON| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,122,564 | Correlation of digoxin-tablet dissolution-rate with biological availability. | Lancet | 1973 | https://conductscience.org/library/papers/4122564 | PubMed |
| 2 | 1,159,622 | Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses. | J Pharmacokinet Biopharm | 1975 | https://conductscience.org/library/papers/1159622 | PubMed |
| 3 | 4,827,467 | Intravenous digoxin as a bioavailability standard: slow infusion and rapid injection. | Clin Pharmacol Ther | 1974 | https://conductscience.org/library/papers/4827467 | PubMed |
| 4 | 4,850,764 | Bioavailability and dissolution properties of two commercial digoxin tablets. | J Pharm Sci | 1974 | https://conductscience.org/library/papers/4850764 | PubMed |
| 5 | 1,269,214 | A completely absorbed oral preparation of digoxin. | Clin Pharmacol Ther | 1976 | https://conductscience.org/library/papers/1269214 | PubMed |
| 6 | 1,122,665 | Letter: Intravenous digoxin as a bioavailability standard. | Clin Pharmacol Ther | 1975 | https://conductscience.org/library/papers/1122665 | PubMed |
| 7 | 4,752,307 | Pharmacokinetics of digoxin: interpreting bioavailability. | Br Med J | 1973 | https://conductscience.org/library/papers/4752307 | PubMed |
| 8 | 797,491 | Bioavailability of drugs: the digoxin dilemma. | Clin Pharmacokinet | 1976 | https://conductscience.org/library/papers/797491 | PubMed |
| 9 | 959,319 | Assessment of methodology in single-dose studies of digoxin bioavailability. | Pharmacology | 1976 | https://conductscience.org/library/papers/959319 | PubMed |
| 10 | 4,644,642 | An overview of the analysis and interpretation of bioavailability studies in man. | Pharmacology | 1972 | https://conductscience.org/library/papers/4644642 | PubMed |
| 11 | 4,412,196 | Bioavailability of digoxin tablets and elixir in the fasting and postprandial states. | Clin Pharmacol Ther | 1974 | https://conductscience.org/library/papers/4412196 | PubMed |
| 12 | 957,127 | Biased bioavailability estimates. | J Pharm Sci | 1976 | https://conductscience.org/library/papers/957127 | PubMed |
| 13 | 859,101 | Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses. | J Pharmacokinet Biopharm | 1977 | https://conductscience.org/library/papers/859101 | PubMed |
| 14 | 4,426,150 | Comparison of one- and six-day urinary digoxin excretion in single-dose bioavailability studies. | Clin Pharmacol Ther | 1974 | https://conductscience.org/library/papers/4426150 | PubMed |
| 15 | 4,741,375 | Curve fitting by spline and Akima methods: possibility of interpolation error and its suppression. | Phys Med Biol | 1973 | https://conductscience.org/library/papers/4741375 | PubMed |
| 16 | 4,758,424 | Biological availability of digoxin from Lanoxin produced in the United Kingdom. | Br Med J | 1973 | https://conductscience.org/library/papers/4758424 | PubMed |
| 17 | 4,479,121 | Equivalent bioavailability from digoxin elixir and rapid-dissolution tablets. | JAMA | 1974 | https://conductscience.org/library/papers/4479121 | PubMed |
| 18 | 10,123 | Effect of sulfasalazine on digoxin bioavailability. | Clin Pharmacol Ther | 1976 | https://conductscience.org/library/papers/10123 | PubMed |
| 19 | 4,678,961 | Absorption of orally given digoxin preparations. | JAMA | 1972 | https://conductscience.org/library/papers/4678961 | PubMed |
| 20 | 4,739,492 | Equivalence lack in digoxin plasma levels. | JAMA | 1973 | https://conductscience.org/library/papers/4739492 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/925886/references